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Persistent and relapsing infections, despite apparently adequate antibiotic therapy,
occur frequently with many pathogens, but it is an especially prominent problem
with Staphylococcus aureus infections. For the purposes of this review, persistence
will encompass both of the concepts of long term survival within the host, including
colonization, and the concept of resisting antibiotic therapy even when susceptible in the
clinical microbiology laboratory. Over the past two decades, the mechanisms whereby
bacteria achieve persistence are slowly being unraveled. S. aureus small colony variants
(SCVs) are linked to chronic, recurrent, and antibiotic-resistant infections, and the study
of SCVs has contributed significantly to understanding of persistence. In our earlier work,
defects in electron transport and thymidylate biosynthesis were linked to the development
of the SCV phenotype (reviewed in 2006), thus this work will be discussed only briefly.
Since 2006, it has been found that persistent organisms including SCVs are part of the
normal life cycle of bacteria, and often they arise in response to harsh conditions, e.g.,
antibiotics, starvation, host cationic peptides. Many of the changes found in these early
SCVs have provided a map for the discovery mechanisms (pathways) for the development
of persistent organisms. For example, changes in RNA processing, stringent response,
toxin-antitoxin, ribosome protein L6 (RplF), and cold shock protein B (CspB) found in SCVs
are also found in other persisters. In addition, many classic persister organisms also show
slow growth, hence SCVs. Recent work on S. aureus USA300 has elucidated the impact
of aerobic expression of arginine deiminase genes on its ability to chronically colonize
the skin and survive in abscesses. S. aureus SCVs also express arginine deiminase
genes aerobically as well. Thus, many pathways found activated in electron transport
type of SCVs are also increased in persisters that have intact electron transport. Many
of these changes in metabolism result in slow growth; hence, small colonies are formed.
Another common theme is that slow growth is also associated with reduced expression
of virulence factors and enhanced uptake/survival within host cells. These adaptations
to survive within the host are rooted in responses that were required for organisms to
survive in a harsh environment long before they were mammals on the earth.
Keywords: Staphylococcus aureus, small colony variants, metabolism, RNA processing, post-transcriptional,
persistence
INTRODUCTION
Persistent and relapsing infections, despite organism susceptibil-
ity and apparently adequate antibiotic therapy, occur frequently
with many pathogens, but it is an especially prominent problem
with Staphylococcus aureus infections (Lowy, 1998). The basis for
persistence has been slowly unraveled over the past two decades,
and many of the pathways involve changes in metabolism. One
phenotype of microorganisms has helped to pave the way to
understand persistence, and this is represented by small colony
variants (SCVs) (Proctor et al., 2006). The linkage between
S. aureus SCVs and persistent infection was first reported in
a small clinical series in 1995 (Proctor et al., 1995). Because
S. aureus SCVs were able to establish an intracellular infection in
cultured cells, it was hypothesized that this might form the basis
for the development of persistent infections (Balwit et al., 1994).
Moreover, the instability of these SCVs wherein they could revert
to the parental normal phenotype would also provide a mech-
anism for relapsing, virulent infections. An important part of
the ability to persist was associated with the quiescent metabolic
state (Proctor et al., 1995). S. aureus SCVs were found to pro-
duce fewer lytic enzymes, thereby allowing them to persist within
the host cells (Proctor et al., 2006). Since then, further work
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has demonstrated enhanced uptake by S. aureus SCVs due to a
high expression of adhesins that facilitate host cell uptake (Sendi
and Proctor, 2009; Tuchscherr et al., 2010). Early studies sug-
gested that the intracellular milieu could select for SCVs (Vesga
et al., 1996), perhaps because cationic antimicrobial peptides,
e.g., lactoferrin, provide the selective pressure within host cells
(Samuelsen et al., 2005; Gläser et al., 2014). While early stud-
ies suggested that the intracellular milieu could select for SCVs
(Vesga et al., 1996), more recent and detailed studies demon-
strated that a high percentage of the initial inoculum (as much as
25%) of S. aureus could undergo phenotypic switching to produce
SCVs (Tuchscherr et al., 2011). This was shown to not only occur
in tissue culture, but also within the kidneys and bones of these
intravenously challenged mice (Horst et al., 2012). The SCVs
that persisted stimulated a reduced immune response, expressed
increased adhesins, and reduced toxins (Tuchscherr et al., 2010).
Moreover, the failure of S. aureus SCVs to stimulate host cells to
produce hypoxia-inducible factor, which would normally alert the
host to the presence of intracellular pathogens, also is important
for promoting persistence (Werth et al., 2010). Finally, persistence
of S. aureus SCVs may also relate to the relative inefficiency of
antibiotics to clear the organisms with host cells (Garcia et al.,
2013). Thus, S. aureus SCVs have been established as intracellu-
lar pathogens that persist within the host. This review will largely
concentrate upon information that has been published since the
2006 review of SCVs (Proctor et al., 2006) and will emphasize
metabolic mechanisms involved in persistence. S. aureus SCVs as
a model persister organism
How do S, aureus SCVs relate to the broader concept of persis-
tence? Many other species of bacteria that persist within the host
also form SCVs (Proctor et al., 2006). Hence, the specific exam-
ple of S. aureus SCVs is also found within many other pathogenic
species. In addition, persisters share many characteristics, and
these are also part of the SCV life cycle. Persisters and S. aureus
SCVs grow slowly due to decreased metabolic activity (Amato
et al., 2014). A subset of organisms within many bacterial pop-
ulations can be part of the normal growth cycle (Lechner et al.,
2012), and this is certainly true for S. aureus SCVs, which are
part of the normal growth cycle that occurs without any external
stresses (Massey et al., 2001; Edwards, 2012). However, persisters
also form as a response to harsh conditions such as antibiotics,
acid, and starvation stresses (Morikawa et al., 2010). Biofilm for-
mation can be thought of as a persister strategy (Abdallah et al.,
2014). Naturally, persistence is inter-related to chronic coloniza-
tion and chronic infections as these may be considered types of
persistence.
ELECTRON TRANSPORT TYPE OF S. AUREUS SCVs
The initial description of S. aureus SCV persisters identified
alterations in electron transport due to mutations in hemin
and menadione biosynthetic genes, which resulted in a loss of
menaquinone and the heme prosthetic group in cytochromes
(Proctor et al., 2006). Others found that mutations in the
cytochrome c assembly protein (CtaA) also produced SCVs
(Clements et al., 1999). Thymidine auxotrophic SCVs were soon
added (Proctor et al., 2006) to the list of metabolic changes in
SCVs. Mutations in thyA were found to produce SCVs that were
phenotypically very similar to the electron transport deficient
(Chatterjee et al., 2008). The reason that thymidine-dependent
SCVs behaved like electron transport defective organisms came
through decreased Krebs cycle activity (Chatterjee et al., 2005,
2007). Of course, when Krebs cycle is decreased, electron trans-
port is down regulated. It was found that thyA mutation was
associated with decreased aconitase (CitB) abundance. A further
connection became apparent wherein CitB expression requires
ClpC, which is reduced in thyA mutants (Chatterjee et al., 2005,
2007, 2008). Hence, thyA mutants are grouped with organisms
defective in electron transport. All of the electron transport types
of SCVs are able to persist within the host and/or cultured
mammalian cells.
CHANGES IN RNAIII METABOLISM IN ELECTRON
TRANSPORT GROUP OF SCVs
As noted above, slow growth is found in many, but not all, organ-
isms that persist. When examining clinical and tissue-cultured
induced S. aureus SCVs, only ∼20% can be assigned to a defined
auxotrophy (Vesga et al., 1996; Proctor et al., 2006; Tuchscherr
et al., 2011). Therefore, the underlying mechanism for forming a
persistent SCV is unknown. Publications in the past six years have
revealed a number of mutations that result in SCVs, but most of
these have not been examined in clinical SCVs. Surprisingly, many
of these newer mutations can be grouped as being involved with
the ribosome and RNA processing. This will be discussed in the
balance of this article.
One of the first indications that electron transport type of
S. aureus SCVs were atypical for RNA processing came from
the observation that there was a complete absence of RNAIII
(Vaudaux et al., 2002; Kohler et al., 2003, 2008; Kahl et al., 2005),
which is the effector molecule in the quorum sensing appara-
tus, agr (accessory gene regulator), in S. aureus (Novick and
Geisinger, 2008). RNAIII arises from nontranslated portion of the
hld (hemolysin D) gene in the agr operon. RNAIII positively reg-
ulates production of toxins and proteases but negatively regulates
adhesins.
Because agr is a quorum-sensing system, one might postulate
that the decreased growth of electron-transport types of SCVs
simply do not reach sufficient density to activate the quorum-
sensing pathway. This seems unlikely for several reasons. The first
is that SCV colonies on blood agar, wherein the local density is
very high, fail to produce hemolytic colonies, and the hemolysins
are controlled by agr/RNAIII (Proctor et al., 2006). The sec-
ond is that RNAIII is not found in any detectable amount in
SCVs (Vaudaux et al., 2002; Kohler et al., 2003, 2008; Kahl et al.,
2005), which is distinctly unusual in that a basal level of RNAIII
is produced in S. aureus during all phases of growth (Novick
and Geisinger, 2008). Surprisingly, mutation in citB produces a
major growth defect, yet a 14-fold increase in RNAIII was found
in the citB mutant as compared to the parent strain S. aureus
strain. This work was performed in a clinical isolate, SA564, in
TSB supplemented with 0.25% glucose (Somerville et al., 2002).
The differences in RNAIII production were found in the post-
exponential phase of growth, with no differences in the exponen-
tial phase of growth. Finally, RNAIII is reduced under anaerobic
conditions in S. aureus MN8 along with the production of toxic
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shock syndrome toxin–1 (TSST-1) (Pragman et al., 2004), which
is regulated by RNAIII. However, the anaerobic suppression of
TSST-1 production can be reversed if excess quantities of pyruvate
are added to the growth medium, resulting in TSST-1 production
during late stationary phase (Table 1). This shows that the anaer-
obic conditions alone do not block RNAIII-regulated production
of TSST-1, which is consistent with an earlier report where both
pyruvate and uracil were added to the culture medium (Sarafian
and Morse, 1987). Taken together, these data strongly suggest an
altered RNAIII metabolism when electron transport is reduced,
which is not simply due to reduced growth/concentration of the
quorum-sensing peptide.
There is a strong inverse connection between agr, hence
RNAIII, and persistent infection. The loss of the major virulence
factor regulator in S. aureus, agr, has been associated with chronic
infections. These agr mutants have been obtained from clinical
isolates from patients with long-term lung infections (cystic fibro-
sis) (Kahl et al., 2005; Hirschhausen et al., 2013), chronic catheter
infections (Rothfork et al., 2003; Yarwood and Schlievert, 2003),
and chronic soft tissue infections (Schwan et al., 2003; Beenken
et al., 2004). Of interest, the development of skin abscesses
requires the presence of agr to establish the initial infection, but
persistence within the abscess is associated with decreased RNAIII
(Wright et al., 2005). Thus, these infections are strongly linked
to situations wherein the organism persists within the host and
resists antibiotic therapy. This suggests that a complete absence of
the RNAIII effector molecule from the agr operon is associated
with persistence.
THE RNA DEGRASOME AND SCVs
Of interest, small colonies and changes in RNA metabolism are
seen in mutants in cshA, cspB, rsaE, rplF, mazF, and rsh (see
Table 2). The role of these mutations in persistent infection is
discussed in the balance of this manuscript.
Low levels of RNAIII can occur by two mechanisms. The agr
quorum-sensing operon may produce less RNAIII or there may
be increased RNAIII degradation to account for low levels of
RNAIII. As noted above, the low RNAIII levels in electron trans-
port type of SCVs are more likely related to increased RNAIII
degradation. The RNA degrasome in S. aureus has recently been
elucidated (Roux et al., 2011; Marincola et al., 2012; Redder and
Linder, 2012; Oun et al., 2013), and a number of degrasome pro-
teins are increased in SCVs as suggested by transcriptomics and
proteomics data from hemB and menD mutant SCVs (Seggewiss
Table 1 | Anaerobic production of toxic shock syndrome toxin – 1.
mM Pyruvate added ng TSST-1/106 cfu
0 0.7
40 0.05
200 24.6
400 63
Exogenous pyruvate and anaerobic toxin production in S. aureus MN8 grown in
tryptic soy broth for 18 h under anaerobic conditions, and supernatants collected
for TSST-1 measurements. TSST-1 was measured by an ELISA as previously
described (McNamara et al., 2009).
et al., 2006; Kriegeskorte et al., 2011). A model of the RNA
degrasome is provided in Figure 1.
The hemBmutant SCV has increased enolase, helicase (CshA),
RsaA (a small noncoding RNA involved in stress responses and
biofilm formation), cspB (cold shock protein B), SigB, SarA,
and FruR (Seggewiss et al., 2006; Kriegeskorte et al., 2011). Of
note, metabolism is embedded in the degrasome with enolase
and phosphofructokinase (Pfk) directly interacting with CshA,
but the effects that they have on CshA has yet to be character-
ized. Some of the targets of the degrasome are small nonprotein
coding RNAs (sRNAs) that control central carbon metabolism
(Geissmann et al., 2009; Bohn et al., 2010; Felden et al., 2011;
Guillet et al., 2013; Romilly et al., 2014; Xue et al., 2014), and
SCVs show changes in the levels of these sRNAs (Abu-Qatousch
et al., 2010). This is not surprising as SCVs showed markedly
increased levels of SigB (Mitchell et al., 2013), which positively
regulates RsaA (Felden et al., 2011), and decreased levels of RsaE
that regulates central carbon metabolism. The low levels of RsaE
in SCVs are likely due to low levels of RNAIII, which is posi-
tively RsaE (Donegan and Cheung, 2009; Donegan et al., 2010;
Guillet et al., 2013). In Bacillus subtilis, CspB associates with
CshA (Hunger et al., 2006). CspB is included in the degrasome,
and it is increased in hemB mutant SCVs (Seggewiss et al., 2006;
Kriegeskorte et al., 2011). RNase Y processes saeRSmRNA so that
it is active. (Marincola et al., 2012). Thus, as changes in RNA
processing impact virulence factor production, TCA cycle, and
biofilms, a number of the phenotypic characteristics of SCVs may
be attributable to RNA processing.
A mutation in the ATP-dependent hellicase, cshA, in S. aureus
results in a temperature-dependent SCV, with reduced growth
at 30◦C and complete growth inhibition at 22◦C (Oun et al.,
2013). Disruption of cshA results in higher RNAIII stability with
increased hemolysis and reduced biofilm formation. Knocking
agrA reversed the phenotype, indicating that cshA is genetically
upstream of agr (Oun et al., 2013). In electron transport deficient
SCVs, the higher levels of CshA might be expected to have a role
in the lower levels of RNAIII.
As noted above, another potential element of the degradosome
may be CspB. Of interest, a mutation in cspB in S. aureus also pro-
duces an SCV with reduced pigment production and increased
resistance to aminoglycosides as found in electron transport SCVs
(Duval et al., 2010). Other characteristics of SCVs such as RNAIII
levels and expression of adhesins has not been studied. Similarly,
the ability of the cspBmutant to persist has also not been reported.
SMALL RNAs AND SCVs
Based on investigations of cDNA libraries, phenotype-specific
expression of sRNAs have been described for S. aureus (Abu-
Qatousch et al., 2010). Selected sRNAs have also been found
to in the hemB mutant SCV as compared to the wild type
strain (Abu-Qatousch et al., 2010). Over expression of RsaE give
SCVs that have decreased TCA cycle activity (Geissmann et al.,
2009; Bohn et al., 2010). RsaE pairs with mRNAs of citB, citZ,
and sucCD, thereby inhibiting their translation and reducing
TCA cycle. While detailed metabolic studies are not available,
one would anticipate that these organisms would have reduced
electron transport and behave like electron transport deficient
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Table 2 | Comparison of phenotypes in SCVs and persisters.
Phenotype SCV (men/hem/ctaA) SCV (thyA) cshA cspB RsaE over rplF mutant Increased Rsh constitutively
Also, unsatu- production (Ribosome MazF active(RelA)
rated fatty acids protein L6) (Toxin –AT)
Biochemical Electron Thymidy-late Hellicase (ATP Cold shock Regulatory Fusidic acid Endoribo- ppGpp
transport synthesis dependent) protein small RNA resistance nuclease synthesis
Colony size Small Small Small(22◦C) Small Small Small Small Small
Persistence Yes Yes Yes Yes (↑PSMs)
Hla Decrease Decrease Increase Decreased Increase
Hld Decrease Decrease Increase Increase
Spa Decrease Increase Decrease Decrease Decrease
FnBP Increase Increase Increase
RNAIII Decrease Decrease Increase Decreased Increase(↓RnpA)
CPS Increase Decrease Increase Increase
Biofilm Increase Increase Decrease Increase capsule
TCA Decrease Decrease Decrease ↓sucD/ TCA Increase
ClpC/ClpP Decreased Decrease Decrease
Ilv pathway Increase Increase
ppGpp Increase
Cell wall thick Increased Increased
Pigment Decreased Decreased Decreased Decreased Decreased
Cold growth Increased CspB Decreased Decreased
Antibiotic AGr, βLr, Daptos SXTr, AGr
AG r , aminoglycoside resistant; βLr , betalactam resistant; Daptos, daptomycin susceptible; ClpC, ATP-dependent protease C; ClpP, ATP-dependent protease P; CSP,
capsular polysaccharide; CspB, cold shock protein B; FnBP, fibronectin binding protein; Hla, α-toxin; Hld, δ-toxin; Ilv, Isoleucin, leucine, valine; Spa, Protein A; SXT r,,
sulfamethoxazole-trimethoprim resistant; sucD, succinyl-CoA synthetase subunit alpha; TCA, tricarboxylic acid cycle.
FIGURE 1 | The RNA degrasome is shown with respect to its impact
on RNAIII as low levels of RNAIII are associated with persistent
S. aureus infections. An ATP-dependent S. aureus hellicase (CshA) is
shown at the center with three proteins associated with it: Enolase,
phosphofructokinase (Pfk), and cold shock protein B (CspB). Two RNase are
shown, RNaseY and RnpA. RnpA has activity against RNAIII and its gene is
negatively regulated by the alarmone, ppGpp.
variants. Mutation of a sRNA, rsaA, has been show to alter viru-
lence and cause persistent infection (Romilly et al., 2014). RsaA
binds to MgrA, a global transcriptional regulator, and attenu-
ates the severity of infections while increasing biofilm formation.
Hence, it contributes to chronic infections (Romilly et al., 2014).
The higher levels of RsaA seen in electron transport SCVs
might help to explain the increased biofilm formation in these
variants as RsaA represses the synthesis of MgrA thereby increas-
ing biofilm (Seggewiss et al., 2006). Also, SCVs have been reported
to be readily killed by phagocytes (Quie, 1969), and this is also
true of strains over-expressing RsaA (Seggewiss et al., 2006).
Hence, increased amounts of RsaA may be contributing to the
SCV phenotype. (A more detailed review of sRNAs in S. aureus is
in Felden et al. (2011).
TOXIN-ANTITOXIN, MazEF, AND SCVs
Another system that is involved in mRNA stability in S. aureus is
the MazEF toxin-antitoxin system (Fu et al., 2007, 2009; Donegan
and Cheung, 2009; Donegan et al., 2010; Figure 2). Toxin-
antitoxin systems are produced by many bacteria (Magnuson,
2007) and transcribed as an operon so that the toxin (MazF) is
readily bond and neutralized by the antitoxin (MazE) (Fu et al.,
2007, 2009; Donegan and Cheung, 2009; Donegan et al., 2010).
MazE is an RNase that acts upon selected mRNAs. In S. aureus,
MazE targets sigB, hla, spa mRNAs, but it avoids mRNAs from
recA, gyrB, sarA (Fu et al., 2007, 2009). In most bacteria, the
MazEF system is regulated by feedback inhibition by its own
gene products, but in S. aureus, the negative regulation comes via
SigB (Donegan and Cheung, 2009). The mazEF promoter allows
transcription of not only mazEF but also the sigB operon, and
activation of the mazEF promoter is needed for full SigB activity.
High levels of free MazF result in slow growth (SCVs),
decreased pigment, and persistence, which can be achieved by
overexpression of MazF or increased activity of ATP-dependent
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FIGURE 2 | MazEF are transcripbed as a pair of proteins, and their
transcription is negatively regulated by SigmaB. MazE is an anti-toxin
protein that binds to MazF, thereby preventing its activity. MazF has RNase
activity, which targets selected mRNAs in S. aureus. The ATP-dependent
protease pair, ClpPC, digests the MazE antitoxin, thereby releasing MazF.
Increased MazF has been associated with persistence.
protease system, ClpCP, which proteolytically targets the anti-
toxin, MazE (Fu et al., 2007, 2009; Donegan and Cheung, 2009;
Donegan et al., 2010). This is compatible with the concept that
toxin-antitoxin systems are involved in persistence (Magnuson,
2007). On the other hand, the low levels of ATP and ClpP and
the higher levels σB in electron transport SCVs suggest that the
MazEF system is probably not contributing to persistence in elec-
tron transport SCVs as electron transport SCVs have high levels
of SigB (Mitchell et al., 2013).
MUTATION IN rpLF AND SCVs
The mutations in rlf, which encodes ribosomal protein L6, cause
SCVs that have decreased pigmentation, like electron transport
type of SCVs, and that allow for persistence (Norström et al.,
2007; Lannergård et al., 2011). L6 is required for efficient pro-
tein synthesis, thus it is not surprising that cells with defective
L6 would grow slowly. Rfl is also called FusE, which comes from
the fact that these mutants are resistant to fusidic acid because
of changes in ribosomal protein L6. In addition, rfl mutation in
E. coli results in increased membrane fluidity and aminoglycoside
resistance (Bosl and Böck, 1981), which is also seen with elec-
tron transport deficient SCVs. Aminoglycosides can also select
for simultaneous fusidic acid resistance (Norström et al., 2007;
Lannergård et al., 2011). Of note, in S. aureus, L6 is reduced in
hemB mutants and under anaerobic growth (Fuchs et al., 2007;
Kriegeskorte et al., 2011), suggesting that part of the phenotype
seen in electron transport SCVs may relate to changes in L6. Little
more in terms of the phenotype is known except that many, but
not all of the rfl mutants, also carry mutations in hem or men
(gerC). These would be double SCVs as a mutation in rlf alone
is sufficient to produce an SCV phenotype. Again, we see the
ribosome, hence RNA, being involved in persistence and the SCV
phenotype.
STRINGENT RESPONSE, PERSISTENCE, AND SCVs
When investigating a S. aureus strain from a patient with per-
sistent and recurrent infection, a constitutively active mutation
in rsh, a RelA homolog in S. aureus, was recovered (Gao et al.,
2010). The mutation resulted defective ppGpp hypdrolase activ-
ity, thereby giving high levels of ppGpp and a persistent stringent
response (Gao et al., 2010). Resistance to linezolid was also found.
As ppGpp is the effector molecule in the stringent response
(Geiger et al., 2012, 2014; Geiger and Wolz, 2014), which limits
protein synthesis, it is not surprising that there is a growth defect,
hence small colonies, i.e., an SCV (Geiger et al., 2012, 2014; Geiger
and Wolz, 2014). Mutations in rsh result in reduced virulence
(Geiger et al., 2012, 2014; Geiger andWolz, 2014). Aside from the
small colony size, the rsh mutant does not resemble the electron
transport SCVs because rsh mutants show increased RNAIII and
all of the characteristics seen when the Agr regulon is active.
ARGININE DEIMINASE AND PERSISTENCE
In electron transport deficient SCVs, the agrABDC pathway,
which is responsible for arginine deiminase activity, is markedly
increased aerobically, whereas in the parent strains it is expressed
only anaerobically (Kohler et al., 2003, 2008; Seggewiss et al.,
2006; Makhlin et al., 2007). The anaerobic regulator of this
operon, ArgR, is also significantly increased in the hemB mutant
(Seggewiss et al., 2006), and it also regulates other normally
anaerobic genes (Makhlin et al., 2007). This is of interest because
the arginine catabolic mobile element (ACME) in USA300 is
found along with the SCCmec element and is expressed aerobi-
cally whereas the other arginine deiminase operon are expressed
only anaerobically (Thurlow et al., 2013). S. aureusUSA300 is the
hypervirulent epidemic strain in the USA. Arginine metabolism
by ACME allows S. aureus to survive on the acidic environment
of skin and within skin abscesses because it neutralizes acid with
ammonia released during arginine catabolism (Thurlow et al.,
2013). This provides a mechanism for the epidemiological obser-
vation that USA300 has an increased propensity to colonize the
acidic environment of the skin chronically, which can be consid-
ered a type of persistence (Miko et al., 2012). Within ACME is
another gene, speG, which encodes, spermidine acetyltransferase,
a polyamine-resistance enzyme, thereby allowing S. aureus to sur-
vive spermidine exposure on the skin and in abscesses (Thurlow
et al., 2013). Spermidine is otherwise a toxic product of arginine
metabolism (Thurlow et al., 2013). The elucidation of the role of
ACME in USA300 helps in the understanding how electron trans-
port SCVs are able to survive for longer periods of time than other
strains of S. aureus by using similar metabolic mechanisms.
METABOLISM AND ANTIBIOTIC-PERSISTERS
A large literature is available linking slow growth and resistance
to antibiotics (Wood et al., 2013), and this is also found in
S. aureus (Lechner et al., 2012). Discussing this type of persis-
tence is beyond the scope of this review; however, one specific
gene will be covered as it has a special link between phosphate
metabolism and slow growth, hence an SCV, specifically phoU.
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PhoU is a global negative regulator that regulates genes involved
in central carbon metabolism and cytochrome expression, thus it
provides strong links to the electron transport type of SCVs (Li
and Zhang, 2007; Gardner et al., 2014). In S. aureus, phoU can
be found to be important for resistance to cationic antimicrobial
peptides (Overton et al., 2011), which may relate to expression
of the dlt and snoD operons that have been related to cationic
antimicrobial peptide resistance (Peschel et al., 1999; Bayer et al.,
2006). Both the dlt and snoD operons are regulated by PhoU. We
have found that the electron transport type of SCVs are also per-
sist in the presence of antibiotics and more resistant to cationic
peptides (Koo et al., 1996; Gläser et al., 2014). Studies of S. aureus
phoU mutants ability to persist within the host are not available,
but one would surmise that this may be the case.
CONCLUSIONS
Persistence and metabolism are intimately intertwined (Kahl,
2014), and it can be achieved via altering many pathways. Slow
growth is common theme for persisters. The electron transport
deficient SCVs show changes in many of the other pathways used
for persistence, hence, the studies of these SCVs have a broader
relevance for persistence. Of interest, altered RNA processing is
suggested in the electron transport SCVs by the exceptionally low
levels of RNAIII. A number of other persister types also show
changes in RNA metabolism either directly through the RNA
degrasome or at the ribosome. While the loss of agr is associated
strongly with persistent and chronic infections, it is not associated
with a growth defect. Naturally, there is a clear RNA effect in agr
mutants in that the effector molecule, RNAIII, is not produced.
Thus, there are many connections between the SCV phenotype
and altered mRNA levels. There are also a number of shared phe-
notypic characteristics PhoU mediated changes and SCVs, but
direct connections have yet to be studied. Finally, a growth defect
is seen with high ppGpp levels, but these strains need to be tested
for persistence.
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